Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Capital Expenditures: 2010-2013

Historic Capital Expenditures for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Mar 2013 value amounting to $129,000.

  • Sonoma Pharmaceuticals' Capital Expenditures fell 50.00% to $129,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $257,000, marking a year-over-year decrease of 23.51%. This contributed to the annual value of $80,000 for FY2025, which is 3900.00% up from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Capital Expenditures stood at $129,000 for Q1 2013, which was up 95.45% from $66,000 recorded in Q4 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' Capital Expenditures ranged from a high of $258,000 in Q1 2012 and a low of -$24,000 during Q4 2011.
  • In the last 3 years, Sonoma Pharmaceuticals' Capital Expenditures had a median value of $62,000 in 2011 and averaged $77,111.
  • Per our database at Business Quant, Sonoma Pharmaceuticals' Capital Expenditures plummeted by 340.00% in 2011 and then soared by 375.00% in 2012.
  • Sonoma Pharmaceuticals' Capital Expenditures (Quarterly) stood at $10,000 in 2010, then crashed by 340.00% to -$24,000 in 2011, then spiked by 375.00% to $66,000 in 2012, then plummeted by 50.00% to $129,000 in 2013.
  • Its Capital Expenditures stands at $129,000 for Q1 2013, versus $66,000 for Q4 2012 and $60,000 for Q3 2012.